Evaluation of the Therapeutic Potential of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib in Preclinical Models of Bladder Cancer

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Therapeutic Potential ◽

Growth Factor Receptor ◽

Preclinical Models ◽

Differential radiosensitisation by ZD1839 (Iressa), a highly selective epidermal growth factor receptor tyrosine kinase inhibitor in two related bladder cancer cell lines

British Journal of Cancer ◽

10.1038/sj.bjc.6602299 ◽

2004 ◽

Vol 92 (1) ◽

pp. 125-130 ◽

Cited By ~ 19

Author(s):

S B Maddineni ◽

V K Sangar ◽

J H Hendry ◽

G P Margison ◽

N W Clarke

Keyword(s):

Bladder Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Local administration of epidermal growth factor receptor tyrosine kinase inhibitor may provide a new therapeutic potential for the treatment of intractable upper airway inflammation

Journal of Japan Society of Immunology & Allergology in Otolaryngology ◽

10.5648/jjiao.34.1 ◽

2016 ◽

Vol 34 (1) ◽

pp. 1-7

Author(s):

Kumiko Takezawa ◽

Takao Ogawa ◽

Shino Shimizu ◽

Takeshi Shimizu

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Therapeutic Potential ◽

Growth Factor Receptor ◽

Upper Airway ◽

Local Administration ◽

Effect of an epidermal growth factor receptor tyrosine kinase inhibitor on actin remodeling in an in vitro bladder cancer carcinogenesis model

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-06-0043 ◽

2006 ◽

Vol 5 (7) ◽

pp. 1754-1763 ◽

Cited By ~ 8

Author(s):

Yusheng Jin ◽

Kenneth K. Iwata ◽

Arie Belldegrun ◽

Robert Figlin ◽

Allan Pantuck ◽

...

Keyword(s):

Bladder Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Actin Remodeling ◽

829 The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘iressa’, ZD-1839) and the protein prenyltransferase inhibitor M365408 as potential therapeutics in bladder cancer

European Urology Supplements ◽

10.1016/s1569-9056(04)90821-4 ◽

2004 ◽

Vol 3 (2) ◽

pp. 210

Author(s):

J.L. Dominguez-Escrig ◽

J. Kelly ◽

B.R. Davies

Keyword(s):

Bladder Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Potential Therapeutics

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

10.32388/jfobd7 ◽

2020 ◽

Author(s):

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Association between E-cadherin and sensitivity of hepatocellular carcinoma to treatment with epidermal growth factor receptor tyrosine kinase inhibitor

Academic Journal of Second Military Medical University ◽

10.3724/sp.j.1008.2014.00915 ◽

2014 ◽

Vol 35 (8) ◽

pp. 915

Author(s):

Rong-chun XING ◽

Jun ZHENG ◽

Ping CHEN ◽

Wei-hong ZHENG ◽

Wei LIU ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Glucose metabolism-targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor-induced drug-tolerant persisters

Cancer Science ◽

10.1111/cas.13266 ◽

2017 ◽

Vol 108 (7) ◽

pp. 1368-1377 ◽

Cited By ~ 4

Author(s):

Kei Kunimasa ◽

Tatsuya Nagano ◽

Yohei Shimono ◽

Ryota Dokuni ◽

Tatsunori Kiriu ◽

...

Keyword(s):

Targeted Therapy ◽

Growth Factor ◽

Glucose Metabolism ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Withaferin A ◽

A report of two bronchioloalveolar carcinoma cases which were rapidly improved by treatment with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 ("Iressa"1

Cancer Science ◽

10.1111/j.1349-7006.2003.tb01464.x ◽

2003 ◽

Vol 94 (5) ◽

pp. 453-458 ◽

Cited By ~ 36

Author(s):

Seiji Yano ◽

Takanori Kanematsu ◽

Toyokazu Miki ◽

Yoshinori Aono ◽

Masahiko Azuma ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Bronchioloalveolar Carcinoma ◽

Abstract 419: Presence of pulmonary tuberculosis impair survival in advancedEGFRmutation lung adenocarcinoma patients receiving epidermal growth factor receptor-tyrosine kinase inhibitor

10.1158/1538-7445.am2021-419 ◽

2021 ◽

Author(s):

Yalin Xie ◽

Wei Zhou ◽

An Lei ◽

Zhan Huang ◽

Li Weiwei ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Pulmonary Tuberculosis ◽

Lung Adenocarcinoma ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Enhanced Sensitivity to the HER1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib Hydrochloride in Chemotherapy-Resistant Tumor Cell Lines

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-04-0993 ◽

2005 ◽

Vol 11 (4) ◽

pp. 1572-1578 ◽

Cited By ~ 59

Author(s):

Qun Dai ◽

Yi-He Ling ◽

Marie Lia ◽

Yi-Yu Zou ◽

Glenn Kroog ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Tumor Cell ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Tumor Cell Lines ◽

Enhanced Sensitivity ◽